Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 105 Results

Title
Intervention Indication Therapeutic Area Year Actions
Adagrasib for previously treated KRAS G12C mutated advanced non-small-cell lung cancer Adagrasib (MRTX-849) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Alectinib adjuvant therapy for ALK-positive non-small cell lung cancer Alectinib (Alecensa) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
AMG 510 for KRAS G12c mutated metastatic non-small cell lung cancer - after prior standard therapy Sotorasib (AMG 510) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Amivantamab for advanced non-small-cell lung cancer Amivantamab (JNJ-6372; JNJ-61186372) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Amivantamab with chemotherapy for previously untreated advanced EGFR exon 20 insertion mutations positive non-small cell lung cancer Amivantamab (JNJ-6372; JNJ-61186372) , Chemotherapy Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Amivantamab with lazertinib for previously untreated locally advanced or metastatic non-small-cell lung cancer Amivantamab (JNJ-6372; JNJ-61186372) , Lazertinib Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Atezolizumab for previously untreated recurrent or advanced non-small cell lung cancer unsuitable for platinum-doublet chemotherapy Atezolizumab (Tecentriq; MPDL3280A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Atezolizumab for resected non-small cell lung cancer - adjuvant Atezolizumab (Tecentriq; MPDL3280A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Atezolizumab for stage IV non-squamous or squamous non-small cell lung cancer Atezolizumab (Tecentriq; MPDL3280A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2019 View  |  Download
Atezolizumab in addition to Carboplatin or Cisplatin and Pemetrexed for Stage IV non-squamous non-small cell lung cancer (NSCLC) Atezolizumab (Tecentriq; MPDL3280A) , Carboplatin (Paraplatin) , Cisplatin (Platinol) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2018 View  |  Download
1 2 3 10 11
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications